Boyne Capital and Platt Park Capital have partnered to launch Novellum Longevity as a provider of support services to longevity and functional wellness clinics.
Novellum will operate as a management services organization (MSO) to provide operational support, including shared infrastructure, growth investment, and best practices in marketing, patient engagement, and clinic management, to its partner companies. Novellum is headquartered in Denver and plans to expand nationally through partnerships with other functional medicine and longevity-focused providers.
Novellum’s first acquisition is the buy of ThriveMD, a medical practice specializing in longevity, functional wellness, and regenerative medicine treatments. Specific services provided by ThriveMD include health diagnostics, bioidentical hormone replacement therapy, stem cell therapy, platelet-rich plasma (PRP) treatments, and advanced medical aesthetics. ThriveMD was founded in 2012 by Dr. Scott Brandt and operates two locations, with its primary clinic in Denver, Colorado, and a secondary location in Vail, Colorado.
“We believe Novellum is at the forefront of a major shift in healthcare—where longevity, performance, and preventative care become central to how people live and age,” said Derek McDowell, the managing partner of Boyne Capital.
Industry trends support this comment. A May 2025 Future of Wellness report by McKinsey shows that in the United States alone, wellness represents more than $500 billion in annual spend, growing at 4 to 5 percent each year, and 84 percent of US consumers say wellness is a “top” or “important” priority. In the United Kingdom, that figure is 79 percent, and in China it is 94 percent. Overall, the global wellness market is valued at over $2 trillion, with longevity—or healthy aging—a fast-growing subcategory appealing especially to millennials and Gen Z consumers.
“We are proud to announce the formation of Novellum and look forward to supporting the company’s strategic growth trajectory as consumer preferences for comprehensive proactive medicine continue to strengthen,” said Platt Park’s Managing Partners Jonny Miller and Mario Burstein in a released statement.
Boyne Capital
invests in lower middle-market companies with revenues of less than $100 million and EBITDA of $3 million to $15 million. Sectors of interest include healthcare services, manufacturing, consumer products, and business services. The firm was founded by Mr. McDowell in 2006 and is headquartered in Miami, Florida.
Platt Park Capital invests from $10 million to $50 million of equity in companies with $10 million to $75 million in revenue and EBITDA of $2 million to $10 million. Sectors of interest include healthcare services, business services, and multi-site consumer. Platt Park was founded in 2023 and is headquartered in Denver.
© 2025 Private Equity Professional | August 6, 2025